SBBP
Strongbridge Biopharma plc.
SBBP
SBBP
Delisted
SBBP was delisted on the 5th of October, 2021.
71 hedge funds and large institutions have $95.3M invested in Strongbridge Biopharma plc. in 2020 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 38 increasing their positions, 11 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
38% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 16
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
71
Holding in Top 10
1
Calls
$65K
Puts
$25K
Top Buyers
| 1 | +$1.51M | |
| 2 | +$540K | |
| 3 | +$489K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$414K |
| 5 |
Two Sigma Advisers
New York
|
+$389K |
Top Sellers
| 1 | -$2.31M | |
| 2 | -$2.24M | |
| 3 | -$1.4M | |
| 4 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$840K |
| 5 |
DMK
David M. Knott
|
-$781K |